Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 13/20 | 0.60 |
| ▸ | ASPH | Q12797 | 11/20 | 0.60 |
| ▸ | KDM8 | Q8N371 | 10/20 | 0.60 |
| ▸ | GABRP | O00591 | 1/20 | 0.48 |
| ▸ | GABRD | O14764 | 1/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.48 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.48 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.48 |
| ▸ | GABRE | P78334 | 1/20 | 0.48 |
| ▸ | GABRA6 | Q16445 | 1/20 | 0.48 |
| ▸ | GABRG1 | Q8N1C3 | 1/20 | 0.48 |
| ▸ | GABRG3 | Q99928 | 1/20 | 0.48 |
| ▸ | GABRQ | Q9UN88 | 1/20 | 0.48 |
| ▸ | RIOX2 | Q8IUF8 | 7/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL23884908 | 0.98 | KDM4E (0.58) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL7083217 | 0.85 | KDM4E (0.50) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL19857491 | 0.83 | GABRP (0.63) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL28635523 | 0.83 | KDM4E (0.48) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL13164026 | 0.81 | GABRP (0.50) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL1171098 | 0.80 | KDM4E (0.67) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL20161506 | 0.78 | ASPH (0.44) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL12489210 | 0.78 | GABRP (0.47) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL935259 | 0.78 | KMO (0.51) | KDM4EASPHKDM8GABRPGABRD | |
| SCHEMBL232024 | 0.78 | KDM4E (0.52) | KDM4EASPHKDM8GABRPGABRD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10590343-B2 | Corrosion inhibitor composition for magnesium or magnesium alloys | Helmholtz-Zentrum Geesthacht Zentrum für Material-und Küstenforschung GmbH (DE) | 2020-03-17 | — | — | US | claimed |
| EP-3284847-B1 | CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS | HELMHOLTZ ZENTRUM GEESTHACHT (DE) | 2019-01-02 | — | — | EP | claimed |
| EP-3284847-A1 | CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS | Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH (DE) | 2018-02-21 | — | — | EP | claimed |
| US-20180044590-A1 | Corrosion Inhibitor Composition for Magnesium or Magnesium Alloys | Helmholtz-Zentrum Geesthacht Zentrum für Material-und Küstenforschung GmbH (DE) | 2018-02-15 | — | — | US | claimed |
| EP-0281943-B1 | Substituted pyridine-2,4-carboxylic acid derivatives, process for their preparation, their use as well as medicaments based on these compounds | HOECHST AG (DE) | 1994-01-12 | — | — | EP | claimed |
| US-20230147170-A1 | FACTOR XI ACTIVATION INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2023-05-11 | — | — | US | disclosed |
| US-20230147170-A1 | FACTOR XI ACTIVATION INHIBITORS | MERCK SHARP & DOHME LLC (US) | 2023-05-11 | — | — | US | disclosed |
| WO-2021202254-A1 | FACTOR XI ACTIVATION INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2021-10-07 | — | — | WO | disclosed |
| US-10590343-B2 | Corrosion inhibitor composition for magnesium or magnesium alloys | Helmholtz-Zentrum Geesthacht Zentrum für Material-und Küstenforschung GmbH (DE) | 2020-03-17 | — | — | US | disclosed |
| EP-3284847-B1 | CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS | HELMHOLTZ ZENTRUM GEESTHACHT (DE) | 2019-01-02 | — | — | EP | disclosed |
| EP-3284847-A1 | CORROSION INHIBITOR COMPOSITION FOR MAGNESIUM OR MAGNESIUM ALLOYS | Helmholtz-Zentrum Geesthacht Zentrum für Material- und Küstenforschung GmbH (DE) | 2018-02-21 | — | — | EP | disclosed |
| US-20180044590-A1 | Corrosion Inhibitor Composition for Magnesium or Magnesium Alloys | Helmholtz-Zentrum Geesthacht Zentrum für Material-und Küstenforschung GmbH (DE) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230147170-A1 | FACTOR XI ACTIVATION INHIBITORS | F11, TFPI, F13B | KDM4E 1614/4885ASPH 890/4885KDM8 476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.